OGN vs TWOD · P/E 3.4, rev $3.02B vs rev $412.0M
Organon & Co (OGN) versus Two Harbors Investment Corp. (TWOD) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Two Harbors Investment Corp. (TWOD) common stock listed on NYSE.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported TWOD revenue for 2025-12-31 was $412.0M. Net income was -$454.3M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. TWOD currently screens at market cap $0.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. TWOD currently screens at market cap $0.
Not investment advice. Open the OGN and TWOD stock pages for the full models.
Not investment advice.